Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab with cisplatin and intensity-modulated radiotherapy for head and neck squamous cell carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Dan Zandberg | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-08-01